Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150036/S080

EDWARDS INTUITY Elite Valve, Model 8300AB

Edwards Lifesciences, LLC · Decision date Jul 29, 2026

FDA DECISIONP150036/S080

What did the FDA decide?

FDA records P150036/S080 as a supplement to PMA P150036, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 29, 2026.

FDA approval order statement

a new sampling plan for in-process testing
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Jul 29, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P150036/S080
Regulatory pathway
PMA supplement
Product code
LWR
Decision code
OK30
Decision date
Jul 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: heart-valve, non-allograft tissue.

Product code
LWR
FDA device class
3

For the original device and its historical approval scope, see PMA P150036. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P150036 · Original PMA

    EDWARDS INTUITY ELITE VALVE SYSTEM

  2. P150036/S078 · Related supplement

    EDWARDS INTUITY Elite Valve

  3. P150036/S079 · Related supplement

    Carpentier-Edwards PERIMOUNT Theon RSR Pericardial Aortic Bioprosthesis with ThermaFix tissue process; Carpentier-Edwar

  4. P150036/S080 received

    Application receipt date recorded by FDA.

  5. P150036/S080 · FDA decision

    30-Day Notice

  6. P150036/S081 · Related supplement

    EDWARDS INTUITY Elite Valve System (8300AB)

Timeline entries are records held by MedtechLedger for P150036. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150036

Explore the linked device profile

Other records with product code LWR

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records